<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000518301"><TermName>ATN-161</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of cancer. ATN-161 may prevent the spread of tumor cells and may prevent the growth of new blood vessels that tumors need to grow. It is a type of antiangiogenesis agent.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>ATN-161</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. ATN-161 podría prevenir la diseminación de las células tumorales y la formación de vasos sanguíneos nuevos que los tumores necesitan para crecer. Es un tipo de antiangiogénico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-03-16</DateFirstPublished><DateLastModified>2009-04-21</DateLastModified></GlossaryTerm>
